HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

9th Edition of International Conference on

Neurology and Neurological Disorders

June 20-22, 2024 | Paris, France

Neurology 2023

Xiaoyu Chen

Speaker at Neurology and Neurological Disorders 2023 - Xiaoyu Chen
Shanghai University of Medicine and Health Sciences, China
Title : Relationships between sarcopenia, depressive symptoms, and mild cognitive impairment in Chinese community-dwelling older adults

Abstract:

Background: Mild cognitive impairment (MCI) represents an intermediate state between normal cognitive aging and dementia. We aimed to investigate the asso- ciation and mediation pathways of sarcopenia, including its individual components (muscle mass, muscle strength, and physical performance), and depressive symptoms with MCI in the older adults.
Methods: This cross-sectional study consisting of 1394 community-dwelling Chinese older adults aged 60 years and older in Tianjin and Shanghai, China. Sarcopenia was defined according to the Asian Working Group for Sarcopenia (AWGS) criteria. Depressive symptoms were evaluated by the 30-item Geriatric Depression Scale (GDS). Cognitive function was assessed by Mini-Mental State Examination (MMSE), the Chinese version of the Dementia Rating Scale (CDRS) was used to apply the diagnostic of non-dementia, and instrument activities of daily living (IADL) were used to evaluate daily living activities. Logistic regression and mediation analyses fully adjusted for all potential confounding factors were conducted.
Results: Sarcopenia, handgrip strength, gait speed, and depressive symptoms were associated with MCI. Furthermore, depressive symptoms significantly mediated the association of sarcopenia, handgrip strength, and gait speed with cognitive function. The relationship of depressive symptoms and cognition were also mediated by sarcopenia, handgrip strength, and gait speed.
Conclusions: Our findings suggest that sarcopenia may contribute substantially to the development of MCI in the older adults via depressive symptoms, although the reverse may also be true. These findings may help guide clinicians to better diagnose and manage MCI in the context of concomitant sarcopenia and depressive symptoms.

Audience Take Away

  • Sarcopenia, handgrip strength, gait speed, and depressive symptoms were associated with MCI
  • Depressive symptoms significantly mediated the association of sarcopenia, handgrip strength, and gait speed with cognitive function. The relationship of depressive symptoms and cognition were also mediated by sarcopenia, handgrip strength, and gait speed
  • These findings may help guide clinicians to better diagnose and manage MCI in the context of concomitant sarcopenia and depressive symptoms

Biography:

Dr. Xiaoyu Chen studied Rehabilitation medicine at the Tianjin Medical University, Tianjin and graduated as PhD in 2021. She then joined the research group of Prof. Qi Guo at the Department of Rehabilitation Medicine, Shanghai University of Medicine and Health Sciences, Shanghai. Her main research direction is clinical psychology. She has published more than 10 research articles in SCI(E) journals.

Watsapp